Senators question Allergan CEO on tribe patent deal
Por um escritor misterioso
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
Pharma's contentious inter partes reviews come under Supreme Court scrutiny
Allergan Restasis Patents Invalid in Texas District Court
Allergan Mohawk Tribe Patent Deal
Allergan plc
Allergan Gains Another Approval for Botox Amid Patent Controversy Over Restasis - Xtalks
Senators question Allergan CEO on tribe patent deal
A handful of Allergan's top shareholders want to bring back the old CEO as chairman
U.S. Senators Press Allergan for Details on Patent Deal With Tribe
Senators question Allergan CEO on tribe patent deal
How a Native American tribe came to own one of the world's most valuable patents
A handful of Allergan's top shareholders want to bring back the old CEO as chairman
de
por adulto (o preço varia de acordo com o tamanho do grupo)
